...
首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
【24h】

Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.

机译:肝硬化中动脉粥样硬化的临床和病理危险因素:NASH相关性肝硬化与其他病因性肝硬化之间的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: The precise prevalence of risk factors for atherosclerosis in NASH-related cirrhosis is unknown. The aims of this study were: (1) to compare the prevalence of major risk factors for atherosclerosis between subjects who underwent liver transplantation for NASH-related cirrhosis and those with cirrhosis of other aetiologies and (2) to compare pathologic changes of atherosclerosis within the explants hepatic hilar arteries between the groups. METHODS: Sixty subjects with NASH-related cirrhosis and 60 subjects with cirrhosis of other aetiologies were reviewed retrospectively. Demographic and clinical characteristics related to atherosclerosis were analyzed and compared. The hepatic hilar arteries of the explanted livers were examined for pathologic changes. RESULTS: The prevalence of all coronary artery disease (CAD) risk factors and the metabolic syndrome was significantly higher in NASH-related cirrhosis group compared to cirrhosis of other aetiologies. The proportion of patients with a diagnosis of CAD was also significantly higher in the NASH-related cirrhosis group (21.6% vs. 5%, p=0.005). Pathological examination of hilar arteries showed possible atherosclerotic changes in only 4 cases (3 NASH-related cirrhosis; 1 HCV). CONCLUSIONS: Major risk factors for atherosclerosis are significantly more prevalent in subjects with NASH-related cirrhosis than in subjects with cirrhosis of other aetiologies and are predictive of an increased prevalence of CAD. This study suggests that NASH-related cirrhosis is not protective against atherosclerosis.
机译:背景/目的:NASH相关性肝硬化中动脉粥样硬化危险因素的确切患病率尚不清楚。这项研究的目的是:(1)比较接受过NASH相关性肝硬化的肝移植患者与其他病因性肝硬化患者之间动脉粥样硬化的主要危险因素的患病率,以及(2)比较患者内动脉粥样硬化的病理变化各组之间外植肝肝门动脉。方法:回顾性分析了60例NASH相关性肝硬化患者和60例其他病因性肝硬化患者。分析和比较了与动脉粥样硬化有关的人口统计学和临床​​特征。检查移植肝脏的肝门动脉病理改变。结果:与其他病因性肝硬化相比,NASH相关性肝硬化组中所有冠状动脉疾病(CAD)危险因素和代谢综合征的患病率均显着更高。在NASH相关的肝硬化组中,诊断为CAD的患者比例也显着更高(21.6%对5%,p = 0.005)。肺门动脉的病理检查仅4例显示可能的动脉粥样硬化改变(3例与NASH相关的肝硬化; 1例HCV)。结论:与其他病因性肝硬化患者相比,NASH相关性肝硬化患者中动脉粥样硬化的主要危险因素明显更为普遍,并且可以预示CAD的患病率会增加。这项研究表明,NASH相关的肝硬化对动脉粥样硬化没有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号